These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 972279)

  • 1. Clinical use of tobramycin in patients with surgical infections due to gram-negative bacilli.
    Ishiyama S; Nakayama I; Iwamoto H; Iwai S; Murata I; Ohashi M
    J Infect Dis; 1976 Aug; 134 Suppl():S178-81. PubMed ID: 972279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobramycin: in vitro and clinical evaluation in 30 patients.
    Perkins RL; Saslaw S; Fass RJ; Prior RB; Scholand JF; Hodges GR; Tight RR; Gardner WG
    Am J Med Sci; 1976; 271(3):297-308. PubMed ID: 820196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with tobramycin in the treatment of infections due to gram-negative bacilli.
    Carmalt ED; Cortez LM; Rosenblatt JE
    Am J Med Sci; 1976; 271(3):285-95. PubMed ID: 820195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of tobramycin in urinary tract infections.
    Altucci P; Abbate GF; Gattoni A; Leonessa V
    J Infect Dis; 1976 Aug; 134 Suppl():S139-41. PubMed ID: 787448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriological, clinical, and pharmacological investigations with tobramycin in patients with serious urinary tract infection.
    Iván E; Cstáry KN
    J Infect Dis; 1976 Aug; 134 Suppl():S153-5. PubMed ID: 823274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobramycin in the treatment of severe and complicated urinary tract infections.
    Bailey RR; Peddie B
    N Z Med J; 1976 Jul; 84(567):1-3. PubMed ID: 823477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tobramycin in severe urinary tract infection.
    Bennet AH
    J Infect Dis; 1976 Aug; 134 Suppl():S156-7. PubMed ID: 972285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of tobramycin in respiratory and systemic infections in immunodepressed and normal patients.
    Altucci P; Abbate GF; Alagia I; Leonessa V
    J Infect Dis; 1976 Aug; 134 Suppl():S182-6. PubMed ID: 972280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of tombramycin in the management of severe infections. Clinical and pharmacological data.
    Baron D; Drugeon H; Nicolas F; Courtieu A
    Eur J Intensive Care Med; 1976 Sep; 2(2):89-96. PubMed ID: 964273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
    Feld R; Valdivieso M; Bodey GP; Rodriguez V
    J Infect Dis; 1977 Jan; 135(1):61-6. PubMed ID: 401853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of aminoglycosides in surgical infections.
    Stone HH; Kolb LD; Geheber CE; Dawkins EJ
    Ann Surg; 1976 Jun; 183(6):660-6. PubMed ID: 973753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall clinical experience with aztreonam in the treatment of intraabdominal infections.
    Henry SA
    Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():47-52. PubMed ID: 6352654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion tobramycin combined with carbenicillin for infections in cancer patients.
    Issell BF; Keating MJ; Valdivieso M; Bodey GP
    Am J Med Sci; 1979; 277(3):311-8. PubMed ID: 256433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical study of the use of the new aminoglycoside tobramycin for therapy of infections due to gram-negative bacteria.
    Meyers BR
    Med J Aust; 1977 Oct; 2(3 Pt 2 Suppl):38-40. PubMed ID: 600202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.
    Tally FP; Kellum JM; Ho JL; O'Donnell TF; Barza M; Gorbach SL
    Antimicrob Agents Chemother; 1986 Feb; 29(2):244-9. PubMed ID: 3717931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of gentamicin-resistant bacteria: experience with tobramycin therapy of infections due to gentamicin-resistant organisms.
    Moellering RC; Wennersten C; Kunz LJ
    J Infect Dis; 1976 Aug; 134 Suppl():S40-9. PubMed ID: 972284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli.
    Warren JW; Miller EH; Fitzpatrick B; DiFranco DE; Caplan ES; Tenney JH; Anthony WC
    Rev Infect Dis; 1983; 5 Suppl 1():S173-80. PubMed ID: 6221388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobramycin sulfate: a summary of worldwide experience from clinical trials.
    Bendush CL; Weber R
    J Infect Dis; 1976 Aug; 134 Suppl():S219-34. PubMed ID: 787450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
    Weippl G
    Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.